Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Creative Medical Technology Holdings (CELZ) Income from Continuing Operations (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Income from Continuing Operations for 16 consecutive years, with 1235934.0 as the latest value for Q3 2025.

  • On a quarterly basis, Income from Continuing Operations fell 18.82% to 1235934.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 5961408.0, a 12.1% decrease, with the full-year FY2024 number at 5493481.0, down 3.91% from a year prior.
  • Income from Continuing Operations was 1235934.0 for Q3 2025 at Creative Medical Technology Holdings, roughly flat from 1233303.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 27836019.0 in Q1 2021 to a low of 6215692.0 in Q4 2022.
  • A 5-year average of 306298.16 and a median of 1453952.0 in 2023 define the central range for Income from Continuing Operations.
  • Biggest YoY gain for Income from Continuing Operations was 643.79% in 2021; the steepest drop was 566.91% in 2021.
  • Creative Medical Technology Holdings' Income from Continuing Operations stood at 3875473.0 in 2021, then crashed by 60.39% to 6215692.0 in 2022, then surged by 72.99% to 1678574.0 in 2023, then decreased by 10.46% to 1854074.0 in 2024, then surged by 33.34% to 1235934.0 in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Income from Continuing Operations are 1235934.0 (Q3 2025), 1233303.0 (Q2 2025), and 1638097.0 (Q1 2025).